Clearmind Medicine Inc. (CMND)

NASDAQ: CMND · Real-Time Price · USD

5.94

-0.18 (-2.94%)

At close: Oct 21, 2026, 4:00 PM EDT

6.07

+0.13 (2.19%)

Pre-market: Oct 22, 2026, 7:21 AM EDT

Clearmind Medicine Income Statement

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Selling, General & Admin	6.57	3.61	4.36	4.76	3.17	2.44
Research & Development	2.3	2.06	1.38	1.54	3.08	0.52
Operating Expenses	8.87	5.67	5.74	6.3	6.25	2.97
Operating Income	-8.87	-5.67	-5.74	-6.3	-6.25	-2.97
Interest Expense	-0.01	-0.02	-0.04	-0.01	-0.01	-
Interest & Investment Income	0.24	0.13	0.27	0.09	-	-
Currency Exchange Gain (Loss)	0	0	-0.01	-0.08	-0	-0.03
Other Non Operating Income (Expenses)	0.31	1.13	0.71	-2.19	-0.29	-
EBT Excluding Unusual Items	-8.33	-4.42	-4.81	-8.5	-6.56	-3
Gain (Loss) on Sale of Investments	1.94	0.84	-0.07	-0.11	-0.31	-
Other Unusual Items	-1.1	-0.21	-	-	-	-
Pretax Income	-7.48	-3.79	-4.88	-8.6	-6.87	-3
Income Tax Expense	0.01	0.07	0.38	0.02	0.03	-
Net Income	-7.5	-3.86	-5.25	-8.62	-6.89	-3
Net Income to Common	-7.5	-3.86	-5.25	-8.62	-6.89	-3
Net Income Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Free Cash Flow	-7.07	-4.73	-4.86	-6.3	-3.73	-2.31
EBITDA	-8.86	-5.66	-5.73	-6.28	-6.23	-2.96
D&A For EBITDA	0.01	0.01	0.01	0.02	0.02	0.01
EBIT	-8.87	-5.67	-5.74	-6.3	-6.25	-2.97

SEC Filings: 10-K · 10-Q